Description
What is Semaglutide?
Semaglutide (GLP-1 receptor agonist — 94% homology to native GLP-1) is a 31-amino acid fatty acid-conjugated peptide. Selective GLP-1R agonist activating pancreatic beta cells, hypothalamus, heart, and kidney — driving glucose-dependent insulin secretion, appetite suppression, gastric emptying delay, and direct cardiovascular effects. SELECT CVOT (2023): 20% MACE reduction in obese non-diabetic patients.
Reviews
There are no reviews yet.